More news out of $JNJ: Producing vaccine “at risk,” hoping to create a billion doses. “At risk” means making many more than they need in trial in order to roll them out immediately; they take on the “risk” of the loss should it fail. #UMassNewsLiteracy  https://t.co/jj4faxDXP7